2-(3-Bromo-5-propoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

GC-Kapillarsäule ROTI®Cap-1701, L 30 m, Ø-Innen 0,32 mm, Filmd. 0,50 µm, 1 Stück

4-Difluoromethoxy-3-fluorophenylacetic acid, 95.0%, 10g

4-Chloro-1-methyl-1H-pyrazol-5-amine, 95.0%, 250mg

Pentadecan-8-one, 95.0%, 25g

(1-Ethyl-1H-pyrazol-5-yl)boronic acid, 95.0%, 25g

Chloromethyl isobutyrate, 95.0%, 25g

2-Fluoro-L-phenylalanine, 98.0%, 250mg

3-(4-Chloro-phenyl)-[1,2,4]oxadiazole-5-carboxylic acid ethyl ester, 95.0%, 5g

2-Bromo-5-methylpyrimidine, 98.0%, 250mg

SRC KINASE INHIBITOR I, 95%, 1g

7-Methoxy-4H-chromen-4-one, 95.0%, 25g

(S)-2-Amino-3-(2-chloro-4-hydroxyphenyl)propanoic acid, 95%, 250mg